Abstract
We initiated the present work to determine whether the presence of the HFE C282Y or H63D mutations could be related to the clinical expression of diabetes mellitus type 2. Two hundred and twenty five type 2 consecutive diabetic patients were included and the HFE genotypes were determined. Younger ages of onset of diabetes as well as a longer duration of the disease were detected in patients carrying at least one C282Y allele (p=0.007). An increased prevalence of retinopathy (p=0.014) and of nephropathy (p=0.04) were also detected in individuals carrying at least one C282Y allele in comparison with patients carrying the other alleles. The increased prevalence of retinopathy in C282Y carriers is related to the increased duration of the disease, but we not have detected that the prevalence of nephropathy is associated with the duration of the disease. However, multivariate logistic regression confirms that the prevalence of nephropathy is higher in the group of patients carrying at least one C282Y allele or the H63D/H63D genotype as compared to the group of patients with the wild-type (N/N) or the N/H63D genotype. To our knowledge our study is the first one to report an earlier age of onset in type 2 diabetic patients carrying HFE mutations.
Similar content being viewed by others
References
Bothwell, T. H., Charlton, R. W., and Motulsky, A. G. (1995). In: The metabolic and molecular bases of inherited disease. Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), McGraw-Hill: New York.
Witte, D. I., Crosby, W. H., Edwards, C. Q., Fairbanks, V. F., and Mitros, F. A. (1996). Clin. Chim. Acta 245, 139–200.
Hramiak, M. I., Finegood, D. T., and Adams, P. C. (1997). Clin. Invest. Med. 20, 110–118.
Feder, J. N., Gnirke, A., Thomas, W., et al. (1996). Nature Genet. 13, 399–408.
Salonen, J. T., Toamainen, T. P., and Kontula, K. (2000). Br. Med. J. 321, 1288–1289.
Conte, D., Manachino, D., Colli, A. et al. (1998). Ann. Intern. Med. 128, 370–373.
Kwan, T., Leber, B., Ahuja, S., Carter, R., and Gerstein, H. C. (1998). Clin. Invest. Med. 21, 251–257.
Moczulski, D. K., Grzeszczak, W., and Gawlik, B. (2001). Diabetes Care 24, 1187–1191.
Malecki, M. T., Klupa, T., Walus, M., et al. (2003). Med. Sci. Monit. 9, BR91-BR95.
Cadet, E., Capron, D., Perez, A. S., et al. (2003). J. Intern. Med. 253, 217–224.
Ellervik, C., Madrup-Poulsen, T., Nordesgaard, B. G., et al. (2001). Lancet 358, 1405–1409.
Turnbull, A. J., Mitchison, H. C., Peaston, R. T., et al. (1997). QJM 90, 271–275.
Hegele, R. A., Harris, S. B., and Zinman, B. (1998). Ann. Intern. Med. 129, 587.
Frayling, T., Ellard, S., Grove, J., Walker, M., and Hattersley, A. T. (1998). Lancet 351, 1933–1934.
Braun, J., Donner, H., Plock, K., Rau, H., and Usadel, K. H. (1998). Diabetologia 41, 983–984.
Fernandez-Real, J. M., Vendrell, J., Baiget, M., Gimferrer, E., and Ricart, W. (1999). Diabetes Care 22, 525–526.
Sampson, M. J., Williams, T., Heyburn, P. J., et al. (2000). J. Lab. Clin. Med. 135, 170–173.
Acton, R. T., Barton, J. C., Bell, D. S., Go, R. C., and Roseman, J. M. (2001). Ethn. Dis. 11, 578–584.
Kankova, K., Jansen, E. H., Marova, I., et al. (2002). Exp. Clin. Endocrinol. Diabetes 110, 223–229.
Halsall, D. J., McFarlane, I., Luan, J., Cox, T. M., and Wareham, N. J. (2003). Hum. Mol. Genet. 12, 1361–1365.
Dubois-Laforgue, D., Larger, E., and Timsit, J. (2000). Diabetes Metab. 26, 318–321.
Van Lerberghe, S., Hermans, M. P., Dahan, K., and Buysschaert, M. (2002). Diabetes Metab. 28, 33–38.
Roest, M., van der Schouw, Y. T., de Valk, B., et al. (1999). Circulation 100, 1268–1273.
Fuchs, J., Podda, M., Packer, L., and Kaufmann, R. (2002). Toxicology 180, 169–181.
Sánchez, M., Bruguera, M., Bosch, J., Rodés, J., Ballesta, F., and Oliva, R. (1998). J. Hepatol. 29, 725–728.
Sánchez, M., Bruguera, M., Quintero, E., et al. (2000). Genetic Testing 4, 171–176.
Sánchez, M., Bruguera, M., Rodés, J., and Oliva, R. (2001). Blood Cells Mol. Dis. 27, 35–43.
Sánchez, M., Villa, M., Ingelmo, M., et al. (2003). J. Hepatol. 38, 745–750.
Muñiz, J., Hervada, J., Juane, R., et al. (1995). Diabetes Res. Clin. Pract. 30, 137–142.
Tamayo-Marco, B., Faure-Nogueras, E., Roche-Asensio, M. J., et al. (1997). Diabetes Care 20, 534–546.
Castell, C., Tresserras, R., Serra, J., et al. (1999). Diabetes Res. Clin. Pract. 43, 33–40.
Nankivell, B. J., Tay, Y. C., Boadle, R. A., and Harris, D. C. (1994). Renal Failure 16, 367–381.
Obayashi, H., Kimura, F., Moriwaki, A., et al. (1999). Human Genet. 105, 197–199.
Hashimoto, M., Nakamura, N., Takara, M., et al. (2000). Diabetes Care 23, 975–978.
World Health Organization Group. (1985). Geneva, World Health Org., Tech. Rep. Ser., 727.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oliva, R., Novials, A., Sánchez, M. et al. The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2. Endocr 24, 111–114 (2004). https://doi.org/10.1385/ENDO:24:2:111
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:24:2:111